Superworth

Celcuity EPS CELC

Diluted earnings per share by quarter and over the last twelve months, from 2016.

Last 12 months, to Jun 30, 2026
−$4.30
Latest quarter, Q2 FY26
−$1.44
Fiscal year 2025
−$3.79

Celcuity's earnings per share was −$4.30 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.44.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$3.79n/a
FY2024−$2.81n/a
FY2023−$2.69n/a
FY2022n/an/a
FY2021−$2.22n/a
FY2020−$0.92n/a
FY2019−$0.72n/a
FY2018−$0.73n/a
FY2017−$0.86n/a
FY2016n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$1.44n/a−$4.30
Q1 FY26−$0.97n/a−$3.90
Q4 FY25−$0.97n/a−$3.79
Q3 FY25−$0.92n/a−$3.67
Q2 FY25−$1.04n/a−$3.45
Q1 FY25−$0.86n/a−$3.03
Q4 FY24−$0.85n/a−$2.81
Q3 FY24−$0.70n/a−$2.61
Q2 FY24−$0.62n/a−$2.74
Q1 FY24−$0.64n/a−$2.78
Q4 FY23−$0.65n/a−$2.69
Q3 FY23−$0.83n/a−$2.73

Against its peers

Companies in Medical - Diagnostics & Research nearest Celcuity's size, closest first, today.

CompanyEPS, 12 monthsGrowth
CELCCelcuity−$4.30
CDNACareDx$2.07+116% a year
VCYTVeracyte$1.40+324% a year
BLLNBillionToOne$0.65
LNTHLantheus$4.13+10% a year
CAICaris Life Sciences$0.37
BIOBio-Rad Laboratories$8.25−30% a year
RVTYRevvity$2.10−11% a year
MEDPMedpace$17.05+27% a year
NRCNRC Health$0.25−67% a year
LHLabcorp$12.09+33% a year
Peer median$2.08

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Celcuity

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.